Figure 2.

Percentage of patients experiencing no or mild pain following administration of study medication. Pain assessments made using a 5-point Likert scale. *P < 0.05 for canakinumab 150 mg vs triamcinolone acetonide 40 mg. CI, confidence interval; LS, least-squares.

Schlesinger et al. Arthritis Research & Therapy 2011 13:R53   doi:10.1186/ar3297
Download authors' original image